The future of HR is employee wellbeing!
Join Mark Faiz, CEO of Personalized Prescribing, as he discusses pharmacogenomics testing and how it can support employee mental health in the workplace.
Register now: https://t.co/8WrMwYjXsM
Our new series “Digital TherapeuTalks” is a gathering of people in medical health technology dedicated to digital therapeutics. #DTX is subset of #digitalhealth, are evidence-based therapeutic interventions driven by high quality software programs to prevent, manage, or treat a medical disorder or disease
Click Therapeutics , Inc. develops prescription software applications as medical devices that work independently or in conjunction with pharmacotherapies to treat disease.
Click clinically validates these applications through rigorous randomized, controlled trials to demonstrate safety and efficacy.
Guest: Shaheen E Lakhan, MD, PhD, FAAN Chief Medical Officer
Welcome to Digital TherapeuTalks!!
Listen here on Spotify:
https://t.co/Gx3lZT2nZE
#RxOnX
Did you know genetic testing could offer assistance to those suffering from mental illness? I didn’t until @P3Canada reached out to share their story/
Richmond Hill company offers genetic testing, hope for people affected by mental illness https://t.co/PIikmJtKE3 via @yorkregion
Listos para empezar en Washington DC! Invito a todos los que se interesan por la salud mental en la Regiòn de las Americas a conectarse por Zoom
https://t.co/0glH9QDMGw
Starting today, RBC insurance has added drug compatibility testing to all their health benefit plans, making it free for those who have had trouble finding the right prescription for their mental health needs … and they’ve chosen us. https://t.co/cpXVmFKR3s
Starting today, RBC insurance has added drug compatibility testing to all their health benefit plans, making it free for those who have had trouble finding the right prescription for their mental health needs … and they’ve chosen us. https://t.co/cpXVmFKR3s
Join us for an exclusive webinar on Pharmacogenetics! Learn how genetic variants in MAOA, MAOB, and COMT can affect the response to antidepressive medication.
Register here!
https://t.co/qEswESSfE2
#pgx#pharmacogenetics#medicationresponse #
If you read this article, then you must attend our webinar! We will share exciting findings within our cohort of patients diagnosed with depression and their response to medication #pharmacogenetics#PGX#medicationresponse to register https://t.co/qEswESSfE2
Pain et al. performed a GWAS of antidepressant response and looked at SNP-based heritability, genetic correlations, and PRS prediction.
Check out the full article here: https://t.co/2iKf4npLRW
Join us for a Fascinating Webinar: The Impact of MAOA, MAOB, and COMT on Antidepressant Response: Unveiling Genetic Influences in Treatment Outcomes.
You can't miss it!
Register here https://t.co/taHu56PBl2
Join us for a Fascinating Webinar: The Impact of MAOA, MAOB, and COMT on Antidepressant Response: Unveiling Genetic Influences in Treatment Outcomes.
You can't miss it!
Register here https://t.co/taHu56PBl2
Join us for a Fascinating Webinar: The Impact of MAOA, MAOB, and COMT on Antidepressant Response: Unveiling Genetic Influences in Treatment Outcomes.
You can't miss it!
Register here https://t.co/taHu56PBl2
You are invited!
Join us on our second session of the Canadian Psycho Pharmacogenomics Forum.
The Interplay Between SLC6A4 and HTR1A Gene Variants that May Lead to Failure of SSRIs.
Register here https://t.co/DbwABr8FCG